3.20.1 html 118 311 1 false 48 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.sunbiopharma.com/20191231/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://www.sunbiopharma.com/20191231/role/statement-consolidated-balance-sheets Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://www.sunbiopharma.com/20191231/role/statement-consolidated-balance-sheets-parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.sunbiopharma.com/20191231/role/statement-consolidated-statements-of-operations-and-comprehensive-loss Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Stockholders' Equity (Deficit) Sheet http://www.sunbiopharma.com/20191231/role/statement-consolidated-statements-of-stockholders-equity-deficit Consolidated Statements of Stockholders' Equity (Deficit) Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Cash Flows Sheet http://www.sunbiopharma.com/20191231/role/statement-consolidated-statements-of-cash-flows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 006 - Statement - Consolidated Statements of Cash Flows (Parentheticals) Sheet http://www.sunbiopharma.com/20191231/role/statement-consolidated-statements-of-cash-flows-parentheticals Consolidated Statements of Cash Flows (Parentheticals) Statements 7 false false R8.htm 007 - Disclosure - Note 1 - Business Sheet http://www.sunbiopharma.com/20191231/role/statement-note-1-business Note 1 - Business Notes 8 false false R9.htm 008 - Disclosure - Note 2 - Risks and Uncertainties Sheet http://www.sunbiopharma.com/20191231/role/statement-note-2-risks-and-uncertainties Note 2 - Risks and Uncertainties Notes 9 false false R10.htm 009 - Disclosure - Note 3 - Liquidity and Business Plan Sheet http://www.sunbiopharma.com/20191231/role/statement-note-3-liquidity-and-business-plan Note 3 - Liquidity and Business Plan Notes 10 false false R11.htm 010 - Disclosure - Note 4 - Summary of Significant Accounting Policies Sheet http://www.sunbiopharma.com/20191231/role/statement-note-4-summary-of-significant-accounting-policies Note 4 - Summary of Significant Accounting Policies Notes 11 false false R12.htm 011 - Disclosure - Note 5 - Accrued Expenses Sheet http://www.sunbiopharma.com/20191231/role/statement-note-5-accrued-expenses- Note 5 - Accrued Expenses Notes 12 false false R13.htm 012 - Disclosure - Note 6 - Indebtedness Sheet http://www.sunbiopharma.com/20191231/role/statement-note-6-indebtedness Note 6 - Indebtedness Notes 13 false false R14.htm 013 - Disclosure - Note 7 - Commitments and Contingencies Sheet http://www.sunbiopharma.com/20191231/role/statement-note-7-commitments-and-contingencies Note 7 - Commitments and Contingencies Notes 14 false false R15.htm 014 - Disclosure - Note 8 - Stockholders' Equity (Deficit) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-8-stockholders-equity-deficit Note 8 - Stockholders' Equity (Deficit) Notes 15 false false R16.htm 015 - Disclosure - Note 9 - Stock-based Compensation Sheet http://www.sunbiopharma.com/20191231/role/statement-note-9-stockbased-compensation Note 9 - Stock-based Compensation Notes 16 false false R17.htm 016 - Disclosure - Note 10 - Income Taxes Sheet http://www.sunbiopharma.com/20191231/role/statement-note-10-income-taxes Note 10 - Income Taxes Notes 17 false false R18.htm 017 - Disclosure - Note 11 - Subsequent Events Sheet http://www.sunbiopharma.com/20191231/role/statement-note-11-subsequent-events Note 11 - Subsequent Events Notes 18 false false R19.htm 018 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.sunbiopharma.com/20191231/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://www.sunbiopharma.com/20191231/role/statement-note-4-summary-of-significant-accounting-policies 19 false false R20.htm 019 - Disclosure - Note 4 - Summary of Significant Accounting Policies (Tables) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-4-summary-of-significant-accounting-policies-tables Note 4 - Summary of Significant Accounting Policies (Tables) Tables http://www.sunbiopharma.com/20191231/role/statement-note-4-summary-of-significant-accounting-policies 20 false false R21.htm 020 - Disclosure - Note 5 - Accrued Expenses (Tables) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-5-accrued-expenses-tables Note 5 - Accrued Expenses (Tables) Tables http://www.sunbiopharma.com/20191231/role/statement-note-5-accrued-expenses- 21 false false R22.htm 021 - Disclosure - Note 6 - Indebtedness (Tables) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-6-indebtedness-tables Note 6 - Indebtedness (Tables) Tables http://www.sunbiopharma.com/20191231/role/statement-note-6-indebtedness 22 false false R23.htm 022 - Disclosure - Note 8 - Stockholders' Equity (Deficit) (Tables) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-8-stockholders-equity-deficit-tables Note 8 - Stockholders' Equity (Deficit) (Tables) Tables http://www.sunbiopharma.com/20191231/role/statement-note-8-stockholders-equity-deficit 23 false false R24.htm 023 - Disclosure - Note 9 - Stock-based Compensation (Tables) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-9-stockbased-compensation-tables Note 9 - Stock-based Compensation (Tables) Tables http://www.sunbiopharma.com/20191231/role/statement-note-9-stockbased-compensation 24 false false R25.htm 024 - Disclosure - Note 10 - Income Taxes (Tables) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-10-income-taxes-tables Note 10 - Income Taxes (Tables) Tables http://www.sunbiopharma.com/20191231/role/statement-note-10-income-taxes 25 false false R26.htm 025 - Disclosure - Note 2 - Risks and Uncertainties (Details Textual) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-2-risks-and-uncertainties-details-textual Note 2 - Risks and Uncertainties (Details Textual) Details http://www.sunbiopharma.com/20191231/role/statement-note-2-risks-and-uncertainties 26 false false R27.htm 026 - Disclosure - Note 3 - Liquidity and Business Plan (Details Textual) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-3-liquidity-and-business-plan-details-textual Note 3 - Liquidity and Business Plan (Details Textual) Details http://www.sunbiopharma.com/20191231/role/statement-note-3-liquidity-and-business-plan 27 false false R28.htm 027 - Disclosure - Note 4 - Summary of Significant Accounting Policies (Details Textual) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-4-summary-of-significant-accounting-policies-details-textual Note 4 - Summary of Significant Accounting Policies (Details Textual) Details http://www.sunbiopharma.com/20191231/role/statement-note-4-summary-of-significant-accounting-policies-tables 28 false false R29.htm 028 - Disclosure - Note 4 - Summary of Significant Accounting Policies - Anti-dilutive Securities (Details) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-4-summary-of-significant-accounting-policies-antidilutive-securities-details Note 4 - Summary of Significant Accounting Policies - Anti-dilutive Securities (Details) Details 29 false false R30.htm 029 - Disclosure - Note 5 - Accrued Expenses - Accrued Expenses (Details) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-5-accrued-expenses-accrued-expenses-details Note 5 - Accrued Expenses - Accrued Expenses (Details) Details 30 false false R31.htm 030 - Disclosure - Note 6 - Indebtedness (Details Textual) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-6-indebtedness-details-textual Note 6 - Indebtedness (Details Textual) Details http://www.sunbiopharma.com/20191231/role/statement-note-6-indebtedness-tables 31 false false R32.htm 031 - Disclosure - Note 6 - Indebtedness - Changes in Debt (Details) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-6-indebtedness-changes-in-debt-details Note 6 - Indebtedness - Changes in Debt (Details) Details 32 false false R33.htm 032 - Disclosure - Note 7 - Commitments and Contingencies (Details Textual) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-7-commitments-and-contingencies-details-textual Note 7 - Commitments and Contingencies (Details Textual) Details http://www.sunbiopharma.com/20191231/role/statement-note-7-commitments-and-contingencies 33 false false R34.htm 033 - Disclosure - Note 8 - Stockholders' Equity (Deficit) (Details Textual) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-8-stockholders-equity-deficit-details-textual Note 8 - Stockholders' Equity (Deficit) (Details Textual) Details http://www.sunbiopharma.com/20191231/role/statement-note-8-stockholders-equity-deficit-tables 34 false false R35.htm 034 - Disclosure - Note 8 - Stockholders' Deficit - Common Stock Reserved for Future Issuance (Details) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-8-stockholders-deficit-common-stock-reserved-for-future-issuance-details Note 8 - Stockholders' Deficit - Common Stock Reserved for Future Issuance (Details) Details 35 false false R36.htm 035 - Disclosure - Note 9 - Stock-based Compensation (Details Textual) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-9-stockbased-compensation-details-textual Note 9 - Stock-based Compensation (Details Textual) Details http://www.sunbiopharma.com/20191231/role/statement-note-9-stockbased-compensation-tables 36 false false R37.htm 036 - Disclosure - Note 9 - Stock-based Compensation - Summary of Option Activity (Details) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-9-stockbased-compensation-summary-of-option-activity-details Note 9 - Stock-based Compensation - Summary of Option Activity (Details) Details 37 false false R38.htm 037 - Disclosure - Note 9 - Stock-based Compensation - Nonvested Share Activity (Details) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-9-stockbased-compensation-nonvested-share-activity-details Note 9 - Stock-based Compensation - Nonvested Share Activity (Details) Details 38 false false R39.htm 038 - Disclosure - Note 9 - Stock-based Compensation - Options Outstanding (Details) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-9-stockbased-compensation-options-outstanding-details Note 9 - Stock-based Compensation - Options Outstanding (Details) Details 39 false false R40.htm 039 - Disclosure - Note 9 - Stock-based Compensation - Assumptions Used in Calculating Fair Value of Options (Details) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-9-stockbased-compensation-assumptions-used-in-calculating-fair-value-of-options-details Note 9 - Stock-based Compensation - Assumptions Used in Calculating Fair Value of Options (Details) Details 40 false false R41.htm 040 - Disclosure - Note 10 - Income Taxes (Details Textual) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-10-income-taxes-details-textual Note 10 - Income Taxes (Details Textual) Details http://www.sunbiopharma.com/20191231/role/statement-note-10-income-taxes-tables 41 false false R42.htm 041 - Disclosure - Note 10 - Income Taxes - Deferred Tax Assets and Liabilities (Details) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-10-income-taxes-deferred-tax-assets-and-liabilities-details Note 10 - Income Taxes - Deferred Tax Assets and Liabilities (Details) Details 42 false false R43.htm 042 - Disclosure - Note 10 - Income Taxes - Income Tax Reconciliation (Details) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-10-income-taxes-income-tax-reconciliation-details Note 10 - Income Taxes - Income Tax Reconciliation (Details) Details 43 false false R44.htm 043 - Disclosure - Note 10 - Income Taxes - Net Operating Losses and Tax Credit Carryforwards (Details) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-10-income-taxes-net-operating-losses-and-tax-credit-carryforwards-details Note 10 - Income Taxes - Net Operating Losses and Tax Credit Carryforwards (Details) Details 44 false false R45.htm 044 - Disclosure - Note 11 - Subsequent Events (Details Textual) Sheet http://www.sunbiopharma.com/20191231/role/statement-note-11-subsequent-events-details-textual Note 11 - Subsequent Events (Details Textual) Details http://www.sunbiopharma.com/20191231/role/statement-note-11-subsequent-events 45 false false All Reports Book All Reports snbp-20191231.xml snbp-20191231.xsd snbp-20191231_cal.xml snbp-20191231_def.xml snbp-20191231_lab.xml snbp-20191231_pre.xml http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/srt/2019-01-31 http://fasb.org/us-gaap/2019-01-31 true true